
Photo: latimes.com
Aug 11, 2025, 05:47
Pat Soon-Shiong: Reviewing Exciting Multi-Tumor Data from Patients on the Bioshield Platform
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared on X:
“Sorry for the pause in Cancer Decoded.
Have been busy reviewing amazing data in multiple different tumor types in patients receiving the Bioshield platform… from patients with brain tumors who failed current standards of care to rare forms of Lymphoma.
News out this week.”
More posts featuring The Author.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 11, 2025, 04:13
Aug 10, 2025, 23:47
Aug 10, 2025, 23:35
Aug 10, 2025, 22:26
Aug 10, 2025, 22:13